AAAAAA

   
Results: 1-12 |
Results: 12

Authors: SACHDEO RC NARANGSACHDEO S MONTGOMERY PA SHUMAKER RC PERHACH JL LYNESS WH ROSENBERG A
Citation: Rc. Sachdeo et al., EVALUATION OF THE POTENTIAL INTERACTION BETWEEN FELBAMATE AND ERYTHROMYCIN IN PATIENTS WITH EPILEPSY, Journal of clinical pharmacology, 38(2), 1998, pp. 184-190

Authors: KAPETANOVIC IM TORCHIN CD THOMPSON CD MILLER TA MCNEILLY PJ MACDONALD TL KUPFERBERG HJ PERHACH JL SOFIA RD STRONG JM
Citation: Im. Kapetanovic et al., POTENTIALLY REACTIVE CYCLIC CARBAMATE METABOLITE OF THE ANTIEPILEPTICDRUG FELBAMATE PRODUCED BY HUMAN LIVER-TISSUE IN-VITRO, Drug metabolism and disposition, 26(11), 1998, pp. 1089-1095

Authors: GLUE P BANFIELD CR PERHACH JL MATHER GG RACHA JK LEVY RH
Citation: P. Glue et al., PHARMACOKINETIC INTERACTIONS WITH FELBAMATE - IN-VITRO IN-VIVO CORRELATION, Clinical pharmacokinetics, 33(3), 1997, pp. 214-224

Authors: BRONSKY EA MELTZER EO PERHACH JL ROSENBERG A LYNESS WH
Citation: Ea. Bronsky et al., CARDIAC SAFETY OF AZELASTINE FOLLOWING 8 WEEKS OF INTRANASAL ADMINISTRATION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1809-1809

Authors: MORGANROTH J LYNESS WH PERHACH JL MATHER GG HARR JE TRAGER WF LEVY RH ROSENBERG A
Citation: J. Morganroth et al., LACK OF EFFECT OF AZELASTINE AND KETOCONAZOLE COADMINISTRATION ON ELECTROCARDIOGRAPHIC PARAMETERS IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 37(11), 1997, pp. 1065-1072

Authors: SACHDEO R NARANGSACHDEO SK SHUMAKER RC PERHACH JL LYNESS WH ROSENBERG A
Citation: R. Sachdeo et al., TOLERABILITY AND PHARMACOKINETICS OF MONOTHERAPY FELBAMATE DOSES OF 1,200-6,000 MG DAY IN SUBJECTS WITH EPILEPSY/, Epilepsia, 38(8), 1997, pp. 887-892

Authors: BUSSE WW MIDDLETON E STORMS W DOCKHORN RJ CHU TJ GROSSMAN J WEILER JM BRONSKY EA MANSFIELD LE BELL TD HEMSWORTH GR PERHACH JL DELETTO TA DAM A
Citation: Ww. Busse et al., CORTICOSTEROID-SPARING EFFECT OF AZELASTINE IN THE MANAGEMENT OF BRONCHIAL-ASTHMA, American journal of respiratory and critical care medicine, 153(1), 1996, pp. 122-127

Authors: BANFIELD CR ZHU GRR JEN JF JENSEN PK SCHUMAKER RC PERHACH JL AFFRIME MB GLUE P
Citation: Cr. Banfield et al., THE EFFECT OF AGE ON THE APPARENT CLEARANCE OF FELBAMATE - A RETROSPECTIVE ANALYSIS USING NONLINEAR MIXED-EFFECTS MODELING, Therapeutic drug monitoring, 18(1), 1996, pp. 19-29

Authors: MORGANROTH J PERHACH JL LYNESS W ROSENBERG A
Citation: J. Morganroth et al., LACK OF EFFECT OF AZELASTINE ALONE AND COADMINISTERED WITH KETACONAZOLE ON ELECTROCARDIOGRAPHIC PARAMETERS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 282-282

Authors: GLUE P BANFIELD CR COLUCCI RD PERHACH JL
Citation: P. Glue et al., COMMENT - WARFARIN-FELBAMATE INTERACTION, The Annals of pharmacotherapy, 28(12), 1994, pp. 1412-1413

Authors: WAGNER ML GRAVES NM LEPPIK IE REMMEL RP SHUMAKER RC WARD DL PERHACH JL
Citation: Ml. Wagner et al., THE EFFECT OF FELBAMATE ON VALPROIC ACID DISPOSITION, Clinical pharmacology and therapeutics, 56(5), 1994, pp. 494-502

Authors: RITTER FJ LEPPIK IE DREIFUSS FE RAK I SANTILLI N HOMZIE R DODSON WE GLAUSER TA SACKELLARES JC OLSON L GARAFOLO EA SHIELDS WD FRENCH J SPERLING M KRAMER LD KAMIN M ROSENBERG A SHUMAKER R PERHACH JL DIX R
Citation: Fj. Ritter et al., EFFICACY OF FELBAMATE IN CHILDHOOD EPILEPTIC ENCEPHALOPATHY (LENNOX-GASTAUT SYNDROME) (REPRINTED FROM NEW-ENGLAND JOURNAL OF MED, VOL 328, PG 29, 1993), Hospital formulary, 28, 1993, pp. 29-36
Risultati: 1-12 |